Q32 Bio Appoints José Trevejo as Chief Medical Officer and Ellie Hershberger as Chief Development Officer
Position
Chief Development Officer
Company
Q32 Bio
Description
Q32 Bio Inc. has announced the appointment of Dr. José Trevejo as Chief Medical Officer and Dr
Quick answer
Q32 Bio Appoints José Trevejo as Chief Medical Officer and Ellie Hershberger as Chief Development Officer (September 14, 2026). Q32 Bio is based in Waltham, Massachusetts, United States.
- Who is the new Chief Development Officer at Q32 Bio?
- Q32 Bio named Ellie Hershberger Chief Development Officer, announced September 14, 2026.
- What did Q32 Bio announce on September 14, 2026?
- Q32 Bio Inc. has announced the appointment of Dr. José Trevejo as Chief Medical Officer and Dr
- What does Q32 Bio do?
- Q32 Bio is a clinical stage biotechnology company whose science targets potent regulators of the adaptive immune system to re-balance immunity and is focused on developing innovative therapies for alopecia areata and...
- Where is Q32 Bio based?
- Q32 Bio is based in Waltham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Retension Pharmaceuticals (September 10, 2026), Wave Life Sciences (September 22, 2026), Beam Therapeutics Inc. (September 1, 2026) and Aquestive Therapeutics, Inc. (September 29, 2026) also announced leadership changes within 45 days of Q32 Bio.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Retension Pharmaceuticals Appoints LeAnne Bloedon as EVP of Clinical Development (September 10, 2026)
- Wave Life Sciences Appoints Monika Vnuk as Chief Business Officer (September 22, 2026)
- Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer (September 1, 2026)
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
- Adial Pharmaceuticals Appoints Matthew Davidson as President and CEO (August 29, 2026)
- OS Therapies Appoints Mr. Clem as Chief Commercial Officer and Mr. Knuettel as Chief Financial Officer (October 1, 2026)
Who to call at Q32 Bio, and when
A new leader at Q32 Bio brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Q32 Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Q32 Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Q32 Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Q32 Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Q32 Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.